Yingna Cai - Concepedia

Author

Yingna Cai

Abbott Fund

Also Known As

Y Cai, Yingna Cai

Publications

458

Citations

H-Index

Concepts

All Affiliations

Abbott Fund The University of Texas MD Anderson Cancer Center Abbott (United Kingdom)

About

Yingna Cai is an author at Abbott Fund specializing in medicine, medicinal chemistry, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	110
2	Natural Sciences	1	1	15
3	Public Health	1	1	48
4	Biochemistry	1	1	15
5	Cell Biology	1	1	48

Yingna Cai

Publications

444

Citations

H-Index

Page 1

	Year	Citations
In Vitro Antibacterial Potency and Spectrum of ABT-492, a New Fluoroquinolone Angela M. Nilius, Linus L. Shen, Dena M. Hensey-Rudloff, Antimicrobial Agents and Chemotherapy	2003	113
The Pharmacokinetics and Safety of ABT-751, a Novel, Orally Bioavailable Sulfonamide Antimitotic Agent: Results of a Phase 1 Study Kenneth R. Hande, A. Hagey, Jordan Berlin, Clinical Cancer Research	2006	81
Inhibition and inactivation of murine hepatic ethoxy- and pentoxyresorufin O-dealkylase by naturally occurring coumarins Yingna Cai, Daniel Bennett, Raghunathan V. Nair, Chemical Research in Toxicology	1993	54
Mechanism-Based Inactivation of Hepatic Ethoxyresorufin O-Dealkylation Activity by Naturally Occurring Coumarins Yingna Cai, Wanda Baer‐Dubowska, Mike J. Ashwood-Smith, Chemical Research in Toxicology	1996	51
Effect of O6-benzylguanine on alkylating agent-induced toxicity and mutagenicity. In Chinese hamster ovary cells expressing wild-type and mutant O6-alkylguanine-DNA alkyltransferases. Yingna Cai, Michael H. Wu, Meng Xu‐Welliver, PubMed Dna DamageCell DeathAgt Repair ProteinToxicological MechanismOvarian Cancer	2000	48
Structure–activity relationships of novel potent MurF inhibitors Yu Gu, Alan S. Florjancic, Richard F. Clark, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineRational Drug DesignMechanism Of ActionPharmacotherapy	2003	47
Novel AntibacterialClass Peter J. Dandliker, Steve D. Pratt, Angela M. Nilius, Antimicrobial Agents and Chemotherapy	2003	35
Novel inhibitors of bacterial protein synthesis: structure–activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variants Richard F. Clark, Sanyi Wang, Zhenkun Ma, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryAntimicrobial Drug DiscoveryBioorganic ChemistryPosition 3Biochemistry	2004	15

Page 1